
Bioglita 30mg Tablet
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Pioglitazone (30mg)
Overview Bioglita 30mg Tablet
Glicare 30mg tablets are prescribed for adult patients with type 2 diabetes to manage blood glucose levels. This helps mitigate serious diabetic complications such as vision impairment and kidney disease. Glicare 30mg may be administered alone or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes efficacy. Dosage is determined by your physician and may be adjusted. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical consultation, can elevate blood glucose, increasing the risk of kidney damage, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive treatment plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Common side effects include headache, sinus inflammation, myalgia, and sore throat. Report persistent or bothersome side effects to your doctor. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior to commencing treatment, inform your physician of any history of heart disease, thyroid disorders, or endocrine conditions, as it may be unsuitable. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.
Uses of Bioglita 30mg Tablet
Managing type 2 diabetes
Major Benefits of Bioglita 30mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bioglita 30mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Bioglita 30mg Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Bioglita 30mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bioglita 30mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Bioglita 30mg Tablet works:
Glucobalance 30mg tablets help manage diabetes by enhancing the body's responsiveness to insulin, a hormone crucial for regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Bioglita 30mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Bioglita 30mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Use of Bioglita 30mg Tablet during lactation requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system. Close monitoring of the infant's blood glucose levels is necessary while the mother is taking Bioglita 30mg Tablet.
DrivingSAFE
Driving ability is typically unaffected by Bioglita 30mg tablets.
KidneySAFE IF PRESCRIBED
Bioglita 30mg tablets pose no safety concerns for patients with kidney disease and require no dosage modification.
LiverCAUTION
Patients with liver impairment should use Bioglita 30mg Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Bioglita 30mg Tablets are contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Bioglita 30mg Tablet :
Omit any missed Bioglita 30mg Tablet dose and resume your regular medication schedule; avoid taking a double dose.
Facts to Know About Bioglita 30mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | PPARγ agonist (thiazolidinedione) |
